Flynn James E
Deerfield Mgmt HIF L.P.
DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C)
Deerfield Healthcare Innovations Fund L.P.
Deerfield Mgmt L.P.
Deerfield Mgmt III L.P.
Deerfield Private Design Fund III L.P.
DEERFIELD PARTNERS L.P.
*Possible Member of 10% Group
10% Owner | 2024-02-01 17:29:56 | 2,613,012
0 | 2,613,012 | Form 13G |
Sanderling Venture Partners VI Co Investment Fund LP
Sanderling Ventures Management VI
Sanderling VI Beteiligungs GmbH & Co KG
Sanderling Venture Partners VI LP
Sanderling VI Limited Partnership
Sanderling Ventures VII L.P.
Sanderling Ventures VII (Canada) L.P.
Sanderling Ventures VII Annex Fund L.P.
Sanderling Ventures Management VII
10% Owner | 2024-11-05 15:08:23 | 814,300
1,592,872 | 2,407,172 | Form 4 |
MIDDLETON FRED A
Director
10% Owner | 2024-11-05 15:04:53 | 31,714
1,601,048 | 1,632,762 | Form 4 |
Valence Investments SPV IV LLC
Valence Investments SPV V LLC
Valence Investments SPV VI LLC
10% Owner | 2024-11-06 16:17:55 | 1,217,678
0 | 1,217,678 | Form 13D |
Keyoung Hansoo Michael
Director | 2020-09-29 16:40:20 | 0
1,133,596 | 1,133,596 | Form 4 |
Leheny A. Rachel
CHIEF EXECUTIVE OFFICER
10% Owner | 2024-11-01 13:25:51 | 130,926
740,326 | 871,252 | Form 4 |
WILSON ROBERT N
Director | 2024-11-01 13:22:06 | 417,529
0 | 417,529 | Form 4 |
ORBIMED ADVISORS LLC
OrbiMed Capital GP VI LLC
10% Owner | 2024-02-05 16:48:48 | 297,380
0 | 297,380 | Form 13D |
Bardin Stephen
Chief Financial Officer | 2024-11-15 16:04:55 | 145,000
0 | 145,000 | Form 3 |
Hebbar Sudarshan
Chief Medical Officer | 2024-08-28 19:09:00 | 82,500
0 | 82,500 | Form 4 |
Stauderman Kenneth A.
Chief Scientific Officer | 2024-08-28 19:10:49 | 62,500
0 | 62,500 | Form 4 |
BREUIL ROBERT S
Chief Financial Officer | 2023-03-27 19:56:09 | 35,326
0 | 35,326 | Form 4 |
Salain Daniel
CTOO | 2020-12-10 17:10:59 | 35,000
0 | 35,000 | Form 4 |
Zamiri Parisa
Chief Medical Officer | 2023-03-27 19:59:47 | 28,982
0 | 28,982 | Form 4 |
Cagle Gerald D.
Director | 2021-06-04 18:37:44 | 12,500
0 | 12,500 | Form 4 |
Dunn Michael J.
President and COO | 2024-09-11 17:00:06 | 11,761
0 | 11,761 | Form 4 |
Geffken Daniel E.
Interim CFO | 2024-05-20 19:47:02 | 0
10,000 | 10,000 | Form 4 |
Shaw Allan
Director | 2024-08-28 19:13:34 | 10,000
0 | 10,000 | Form 4 |
BJERKHOLT ERIC
Director | 2024-08-28 19:14:14 | 10,000
0 | 10,000 | Form 4 |
Guerard Frederic
Director | 2024-08-28 19:14:57 | 10,000
0 | 10,000 | Form 4 |
Roberts Eric W
CHIEF BUSINESS OFFICER
10% Owner | 2024-11-06 20:00:07 | 0
3,000 | 3,000 | Form 4/A |
SHAFFER CHRISTY L
Director | 2023-03-27 19:59:08 | 1,429
0 | 1,429 | Form 4 |
ACKERMANN CHRISTINA
Director | 2023-03-27 19:54:44 | 1,429
0 | 1,429 | Form 4 |
EASTLAND JULIA MARIE
Director | 2023-03-27 19:57:01 | 1,429
0 | 1,429 | Form 4 |
Sauer Dirk
Director | 2023-03-27 19:58:21 | 1,429
0 | 1,429 | Form 4 |
Clarus Lifesciences III L.P.
Clarus Ventures III GP L.P.
Blackstone Clarus III L.L.C.
Blackstone Holdings II L.P.
Blackstone Holdings I/II GP L.L.C.
Blackstone Group Inc
Blackstone Group Management L.L.C.
SCHWARZMAN STEPHEN A
10% Owner | 2022-02-11 06:40:04 | 0
0 | 0 | Form 13G |